<?xml version="1.0" encoding="UTF-8"?>
<funding-group>
 <award-group id="award001">
  <funding-source>
   <institution>Merck Investigator Studies Program</institution>
  </funding-source>
  <principal-award-recipient>
   <contrib-id authenticated="true" contrib-id-type="orcid">http://orcid.org/0000-0002-7880-6448</contrib-id>
   <name>
    <surname>Tieu</surname>
    <given-names>Hong-Van</given-names>
   </name>
  </principal-award-recipient>
 </award-group>
 <award-group id="award002">
  <funding-source>
   <institution-wrap>
    <institution-id institution-id-type="funder-id">http://dx.doi.org/10.13039/100000071</institution-id>
    <institution>National Institute of Child Health and Human Development</institution>
   </institution-wrap>
  </funding-source>
  <award-id>HD059729</award-id>
  <principal-award-recipient>
   <name>
    <surname>Koblin</surname>
    <given-names>Beryl A.</given-names>
   </name>
  </principal-award-recipient>
 </award-group>
 <award-group id="award003">
  <funding-source>
   <institution-wrap>
    <institution-id institution-id-type="funder-id">http://dx.doi.org/10.13039/100000026</institution-id>
    <institution>National Institute on Drug Abuse</institution>
   </institution-wrap>
  </funding-source>
  <award-id>DA031035</award-id>
  <principal-award-recipient>
   <contrib-id authenticated="true" contrib-id-type="orcid">http://orcid.org/0000-0002-7880-6448</contrib-id>
   <name>
    <surname>Tieu</surname>
    <given-names>Hong-Van</given-names>
   </name>
  </principal-award-recipient>
 </award-group>
 <award-group id="award004">
  <funding-source>
   <institution-wrap>
    <institution-id institution-id-type="funder-id">http://dx.doi.org/10.13039/100006492</institution-id>
    <institution>Division of Intramural Research, National Institute of Allergy and Infectious Diseases</institution>
   </institution-wrap>
  </funding-source>
  <principal-award-recipient>
   <name>
    <surname>Laeyendecker</surname>
    <given-names>Oliver</given-names>
   </name>
  </principal-award-recipient>
 </award-group>
 <funding-statement>This study was funded by the Merck Investigator Studies Program (MISP) to HVT, 
  <ext-link ext-link-type="uri" xlink:href="http://engagezone.msd.com/misp.php" xmlns:xlink="http://www.w3.org/1999/xlink">http://engagezone.msd.com/misp.php</ext-link>. HVT was supported by the National Institutes of Health K01 DA031035. The NYC M2M study was funded by the National Institutes of Health R01 HD059729 (PI: Koblin). OL was funded by the Division of Intramural Research at the National Institute of Allergy and Infectious Diseases of the National Institutes of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. BioInfoExperts, LLC provided support in the form of salary for R.R., but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific role of this author is articulated in the ‘author contributions’ section.
 </funding-statement>
</funding-group>
